All treatments
Treatment
Matched Placebo to Test clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
A randomized Phase 2, double-blind, placebo-controlled, parallel-group, 2-arm study to assess the efficacy, safety, and tolerability of subcutaneous lunsekimig in adult participants with chronic rhinosinusitis with nasal polyps (CRSwNP)
This study looks at a new medicine called lunsekimig for adults with long-term stuffy nose and growths called nasal polyps. It compares lunsekimig to a dummy medicine to see if it makes symptoms better and if it's safe.
For: Respiratory tract diseasesBulgaria · Poland · Belgium - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2b, randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of 3 subcutaneous dose regimens of lunsekimig (SAR443765) in adult participants with moderate to-severe atopic dermatitis
This study is testing a new medicine called lunsekimig for adults with moderate to severe eczema. We want to see how well it works to reduce eczema symptoms and if it's safe. Participants will receive either the new medicine or a dummy medicine.
For: Dermatitis atopicCzechia · Poland